Results for:(85 found)
Nov 12, 2012 11:26AM on Top StocksBy

Abbott also reports promising results ahead of a big medical meeting.

Nov 9, 2012 12:33PM on Top StocksBy MSN Money Partner

Groupon is downgraded to 'equal weight,' while Isis Pharmaceuticals is upgraded to 'outperform.'

Oct 31, 2012 12:10PM on Top StocksBy TheStreet Staff

The second-generation HIV drug is being developed to counteract expiring patents.

Oct 24, 2012 10:46AM on Top StocksBy TheStreet Staff

The company raises sales guidance while reporting better-than-expected Q3 earnings.

Oct 18, 2012 11:43AM on Top StocksBy Stock Traders Daily

Although Abbott has recently gained on positive trial results, Gilead Sciences remains in the forefront of the market.

Oct 17, 2012 5:25PM on Top StocksBy Jim J. Jubak

Both companies want to develop a replacement to the standard year-long injection treatment.

Sep 13, 2012 2:22PM on Top StocksBy Benzinga

Some stocks in the sector have seen massive gains this year, causing shorts to back off.

Aug 28, 2012 8:14AM on Top StocksBy Melly Alazraki

All eyes remain on the Fed's symposium as traders hope for more stimulus. US home prices rise. Consumer confidence declines. Japan cuts its economic forecast, while Spain's recession deepens. Apple seeks to ban 8 Samsung phones.



Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.


No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.